187 related articles for article (PubMed ID: 1849281)
1. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
MacIntyre I; Zaidi M; Alam AS; Datta HK; Moonga BS; Lidbury PS; Hecker M; Vane JR
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2936-40. PubMed ID: 1849281
[TBL] [Abstract][Full Text] [Related]
2. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism.
Holliday LS; Dean AD; Lin RH; Greenwald JE; Gluck SL
Am J Physiol; 1997 Mar; 272(3 Pt 2):F283-91. PubMed ID: 9087669
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide superoxide and peroxynitrite modulate osteoclast activity.
Mancini L; Moradi-Bidhendi N; Brandi ML; MacIntyre I
Biochem Biophys Res Commun; 1998 Feb; 243(3):785-90. PubMed ID: 9501002
[TBL] [Abstract][Full Text] [Related]
4. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
Alam AS; Gallagher A; Shankar V; Ghatei MA; Datta HK; Huang CL; Moonga BS; Chambers TJ; Bloom SR; Zaidi M
Endocrinology; 1992 Jun; 130(6):3617-24. PubMed ID: 1597159
[TBL] [Abstract][Full Text] [Related]
5. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
Hall TJ
Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.
Zaidi M; Datta HK; Moonga BS; MacIntyre I
J Endocrinol; 1990 Sep; 126(3):473-81. PubMed ID: 2170558
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.
Brandi ML; Hukkanen M; Umeda T; Moradi-Bidhendi N; Bianchi S; Gross SS; Polak JM; MacIntyre I
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2954-8. PubMed ID: 7535933
[TBL] [Abstract][Full Text] [Related]
8. Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".
Zaidi M; Kerby J; Huang CL; Alam T; Rathod H; Chambers TJ; Moonga BS
J Cell Physiol; 1991 Dec; 149(3):422-7. PubMed ID: 1660481
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
10. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
[TBL] [Abstract][Full Text] [Related]
11. Role of the endothelial cell in osteoclast control: new perspectives.
Zaidi M; Alam AS; Bax BE; Shankar VS; Bax CM; Gill JS; Pazianas M; Huang CL; Sahinoglu T; Moonga BS
Bone; 1993; 14(2):97-102. PubMed ID: 8392855
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin effects on isolated bone cells.
Shlossman M; Brown M; Shapiro E; Dziak R
Calcif Tissue Int; 1982 Mar; 34(2):190-6. PubMed ID: 6282413
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic calcium.
Komarova SV; Shum JB; Paige LA; Sims SM; Dixon SJ
Calcif Tissue Int; 2003 Sep; 73(3):265-73. PubMed ID: 14667140
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
16. 8-Nitro-cGMP is a promoter of osteoclast differentiation induced by RANKL.
Kaneko K; Miyamoto Y; Tsukuura R; Sasa K; Akaike T; Fujii S; Yoshimura K; Nagayama K; Hoshino M; Inoue S; Maki K; Baba K; Chikazu D; Kamijo R
Nitric Oxide; 2018 Jan; 72():46-51. PubMed ID: 29183803
[TBL] [Abstract][Full Text] [Related]
17. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents.
Brüne B; Lapetina EG
J Biol Chem; 1989 May; 264(15):8455-8. PubMed ID: 2542278
[TBL] [Abstract][Full Text] [Related]
18. A hypothesis for the local control of osteoclast function by Ca2+, nitric oxide and free radicals.
Alam AS; Huang CL; Blake DR; Zaidi M
Biosci Rep; 1992 Oct; 12(5):369-80. PubMed ID: 1290801
[TBL] [Abstract][Full Text] [Related]
19. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
Mulè F; D'Angelo S; Serio R
Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
[TBL] [Abstract][Full Text] [Related]
20. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Moonga BS; Moss DW; Patchell A; Zaidi M
J Physiol; 1990 Oct; 429():29-45. PubMed ID: 2277349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
